Amlodipine and Atorvastatin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 60505-3483
  • Package NDC 60505-3483-3
  • Application number ANDA205199
  • SPL ID f3607a61-82ce-eafc-1ee7-6eb7ad04fb8b
  • SPL set ID 4c7b1b11-90a3-bc1c-0e45-9e2a14ef0b03
  • UNII 864V2Q084H
  • UNII 48A5M73Z4Q
  • RxCUI 404011
  • RxCUI 404013
  • RxCUI 597967
  • RxCUI 597977
  • RxCUI 597980
  • RxCUI 597984
  • RxCUI 597987
  • RxCUI 597990

What the source publishes

Labeler
Apotex Corp.
Active ingredients
Amlodipine and Atorvastatin
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:60505-3483_f3607a61-82ce-eafc-1ee7-6eb7ad04fb8b
{
  "name": "Amlodipine and Atorvastatin",
  "splId": "f3607a61-82ce-eafc-1ee7-6eb7ad04fb8b",
  "labels": [
    {
      "setId": "4c7b1b11-90a3-bc1c-0e45-9e2a14ef0b03",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c7b1b11-90a3-bc1c-0e45-9e2a14ef0b03",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c7b1b11-90a3-bc1c-0e45-9e2a14ef0b03"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Apotex Corp.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (60505-3483-3)",
      "package_ndc": "60505-3483-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200729"
    }
  ],
  "productId": "60505-3483_f3607a61-82ce-eafc-1ee7-6eb7ad04fb8b",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "60505-3483",
  "deaSchedule": null,
  "genericName": "Amlodipine and Atorvastatin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "AMLODIPINE BESYLATE",
      "strength": "5 mg/1"
    },
    {
      "name": "ATORVASTATIN CALCIUM TRIHYDRATE",
      "strength": "20 mg/1"
    }
  ],
  "applicationNumber": "ANDA205199",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200729",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0360505347933",
      "0360505349333",
      "0360505348930",
      "0360505348435",
      "0360505348336",
      "0360505347834"
    ],
    "unii": [
      "864V2Q084H",
      "48A5M73Z4Q"
    ],
    "rxcui": [
      "404011",
      "404013",
      "597967",
      "597977",
      "597980",
      "597984",
      "597987",
      "597990"
    ],
    "spl_set_id": [
      "4c7b1b11-90a3-bc1c-0e45-9e2a14ef0b03"
    ],
    "manufacturer_name": [
      "Apotex Corp."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:60505-3483_f3607a61-82ce-eafc-1ee7-6eb7ad04fb8b"